selegiline has been researched along with Leukemia, Myeloid, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, Y; Guan, Y; Liu, H; Qin, W; Suo, F; Wang, X; Zhai, X; Zheng, Y | 1 |
| Han, T; Sun, C; Tian, Z; Wang, X | 1 |
| Chung, W; Han, J; Heo, JY; Jang, Y; Ju, X; Kim, SJ; Kweon, GR; Lee, MJ; Lee, YL; Oh, E; Ryu, I; Ryu, MJ; Song, IC; Yoo, BH | 1 |
3 other study(ies) available for selegiline and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone Demethylases; Humans; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Molecular Structure; Stilbenes; Structure-Activity Relationship; THP-1 Cells | 2018 |
Selegiline ameliorated dyslipidemia and hepatic steatosis in high-fat diet mice.
Topics: Animals; Diet, High-Fat; Fatty Liver; Hypercholesterolemia; Leukemia, Myeloid, Acute; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Selegiline | 2023 |
L‑Deprenyl exerts cytotoxicity towards acute myeloid leukemia through inhibition of mitochondrial respiration.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mitochondria; Monoamine Oxidase; Mutation; Oxygen Consumption; Selegiline; Xenograft Model Antitumor Assays | 2018 |